Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome

Summary

This study evaluates the benefits of hydroxychloroquine on arterial function in antiphospholipid syndrome. Briefly, the patients will be randomized in two groups, one will receive hydroxychloroquine and standard treatment, the other will receive placebo in addition of standard treatment.

Timeline

Start

2016-05-17

Primary completion

2020-08-05

Completion

2020-08-05

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty in enrolling new patients”

Drugs

Indications